Sort   by:  
 Page size 
UnknownThe CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome.
Not available
S-EPMC9772048 | biostudies-literature
UnknownDimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity.
Not available
S-EPMC8023410 | biostudies-literature
UnknownReal-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients.
Not available
S-EPMC11782338 | biostudies-literature
UnknownHost Genetic Architecture between Epstein-Barr Virus Activity and Multiple Sclerosis Reveals Shared Pathways.
Not available
S-EPMC12723777 | biostudies-literature
UnknownLong COVID in people with multiple sclerosis and related disorders: a multicenter cross-sectional study.
Not available
S-EPMC12140528 | biostudies-literature
UnknownLong COVID in People With Multiple Sclerosis and Related Disorders: A Multicenter Cross-Sectional Study.
Not available
S-EPMC12698955 | biostudies-literature
UnknownImpact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic.
Not available
S-EPMC9548342 | biostudies-literature
UnknownDiagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis.
Not available
S-EPMC11421977 | biostudies-literature
UnknownEffect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3-T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis.
Not available
S-EPMC10016223 | biostudies-literature
UnknownSex effects across the lifespan in women with multiple sclerosis.
Not available
S-EPMC7331774 | biostudies-literature
Sort   by:  
 Page size